Cantor Fitzgerald Initiates Coverage On Taiwan Liposome Co with Overweight Rating, Announces $11 Price Target

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Taiwan Liposome Co (NASDAQ:TLC) with a Overweight rating and a $11 price target.

Benzinga · 12/23/2019 12:46

Cantor Fitzgerald analyst Kristen Kluska initiates coverage on Taiwan Liposome Co (NASDAQ:TLC) with a Overweight rating and a $11 price target.